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The Moloney murine leukaemia virus replicates in lymphoid
cells and causes exclusively T-cell lymphomas in infected
mice (Des Groseillers et al., 1983). Jaenisch et al. (1981) have
recently described several substrains of mice, designated Mov
1-Mov 14, which each carry a single copy of the
thymotropic Moloney murine leukaemia virus (M-MuLV) as
a stable element of their genome. These mice were derived
from their parental strains by exposing 4-16 cell pre-
implantation embryos to M-MuLV (Mov 1-Mov 12) or
by microinjection of embryos at later stages of development
(Mov 13, 14). While some Mov strains do not express the
viral genome, others, including Mov 3 and Mov 9, become
spontaneously viremic and leukaemic early in life. The
thymus provides the site at which T-lymphocyte generation
and gene rearrangement take place resulting in the
production of cells expressing mature T-cell antigen
receptors. (Owen & Jenkinson, 1981). This organ is also
thought to play an essential role in the process of T-cell
leukaemogenesis, and may be the site of recombinant virus
production and leukaemia initiation (Datta et al., 1983). For
this reason we thought the thymus could be a likely
candidate as a site of virus activation in Mov mice. In order
to test this possibility we have transplanted foetal Mov 3
and Mov 9 thymus, taken before the time of M-MuLV
activation in the embryo, under the kidney capsule of Balb/c
nude mice. Evidence of virus production in the recipients
would demonstrate primary transcription of endogeneous M-
MuLV within the transplanted tissue.
Mov 3 and Mov 9 mice and the C57BL/6 and 129 strains
from which they were derived were originally a gift from Dr
R. Jaenisch of the Heinrich Pette Institut, Hamburg, and are
now breeding successfully in our own animal facility. In
initial experiments 2-6 foetal Mov 3 or Mov 9 thymus lobes
taken at 14 and 12 days gestation respectively, were grafted
perirenally to 8-10 week old Balb/c nude mice. Within 3
months of grafting a high proportion of the recipient mice
developed rapidly growing thymomas at the site of the
thymus graft but not at the site of the rudimentary thymus
of the nude mouse. However the grafted embryonic tissues
had been derived from Mov 3 and Mov 9 mothers, raising
the possibility that low levels of maternal M-MuLV could
have contaminated the transplanted foetal tissues during
dissection. This possibility was confirmed by experiments in
which normal Balb/c foetal spleen or thymus, exposed to 3%
Mov 9 serum for 2h in organ culture, were grafted to Balb/c
nude mice. Grafted mice were tail bled at intervals, and the
sera tested for reverse transcriptase which is detected at high
levels in viremic mice (Goff et al., 1981). Despite repeated
washing of the foetal tissues in fresh RPMI 1640 before
grafting, all of the recipient mice became viremic (Table I).
Only those Balb/c nude mice given a thymus graft became
leukaemic, as would be predicted from the known
requirement for a thymus in T-cell leukaemogenesis
(Levinthall & Buffett, 1961). These results demonstrate the
Correspondence: W.J. Bateman.
Received 5 November 1986; and in revised form, 23 January 1987.
Table I Contamination of grafted tissues with Mov 9 serum
causes viremia and leukaemia in recipient mice
Balb/efoetal No. ofmice Viremia at Leukaemia
tissuea grafted 3 weeksb (3-12 months)
Thymus 4 + +(3/4)
Spleen 4 +
aBalb/c nude mice received 5 foetal Balb/c thymus lobes or
2 spleens taken at 14 days gestation. Grafted mice were also
given 5 x 107 adult Balb/c spleen and lymph node cells i.p. to
provide adequate immune reconstitution in those animals not
given a thymus graft. bViremia was determined by measuring
reverse transcriptase activity in serum samples (Goff et al.,
1981). Briefly 50pl serum diluted 1:10 or 1:20 in PBS was
added to 50pl of a cocktail containing: -0.1 M Tris-HCl
ph8.3, 40mM dithreotol, 1.2mM MnCl2, 0.12M NaCl, 1%
Triton-X, 5 pgml-1 oligodeoxythymidine (Sigma), 20 pgml-
polyadenylic acid (Sigma) and 0.5,uCi 32P-thymidine triphos-
phate (800Cimol-', Amersham International). The mixture
was incubated for 2h at 37°C and transferred on to DEAE
paper (Whatman DE-81). The DEAE paper was washed twice
for 15min in 100ml 2 x SSC, and twice in ethanol. After
drying results were scored by exposure to X-ray film
overnight.
susceptibility of Balb/c nude mice to viremia and leukaemo-
genesis following exposure to low levels of M-MuLV.
In order to avoid maternal virus contamination of foetal
Mov 3 and Mov 9 tissues, recipient nude mice were grafted
with 2-4 thymus lobes taken from (C57BL/6y x Mov 3S)F1
or (129? x Mov 9,S)F1 matings. In this way non-viremic
mothers could be used. These crosses between homozygous
Mov males with their parental strains results in
heterozygous offspring for the Mov locus which are known
to become viremic (Jaenisch et al., 1981; 1983). To separately
test the thymic stroma as compared to the lymphoid
elements of the thymus, in some experiments the grafted
thymic lobes were first organ cultured for 5 days in medium
containing 1.35 mm deoxyguanosine to remove lymphoid
cells as previously described by Jenkinson et al. (1982). In
this case the recipient mice also received 2 normal Balb/c
foetal thymus lobes in order to improve the survival of
grafted mice which were kept under normal animal house
conditions. Viremia was assessed by reverse transcriptase
activity in serial tail bleedings (Table II). Samples were
scored by comparison to viremic Mov 3 or Mov 9 sera as
positive controls and Balb/c nude serum negative controls.
All strains of normal mouse serum tested (Balb/c, Balb/c
nude, C57BL/6, 129) gave routinely negative results in this
assay.
Sera from nude mice grafted with fresh or deoxyguanosine
treated thymus were negative in tests for reverse
transcriptase demonstrating that these mice were not viremic.
Some animals were kept for longer than one year after
grafting. None of the mice developed leukaemia.
Here we have shown that Balb/c nude mice grafted with
embryonic thymus carrying the Mov 3 or Mov 9 locus for
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Table II Reverse transcriptase activity in sera of grafted Balb/c nude mice
Deoxyguanosine No. of Duration exp. Leukaemia
Graft treatment mice (weeks) Viremiaa 3-12 months
(C57BL/6Y x Mov 3)F1 - 3 17 - -
+ 8 10 - -
(129Yx Mov 9)F1 - 7 13 - -
+ 2 13 + b
aViremia was assessed by measurement of reverse transcriptase in serum samples. All strains
of normal mice tested were negative. Mov 3 and Mov 9 and M-MuLV infected Balb/c or Balb/c
nude mice were strongly positive. bOne of two mice was weakly positive for reverse
transcriptase, however in this mouse the thymus graft did not 'take' and the mouse was already
'wasting' at the time of bleeding.
M-MuLV do not become viremic. Only 1 of 9 animals
grafted with (129y x Mov 9,)F1 thymus gave a weakly
positive test for reverse transcriptase. However this mouse
died 2 weeks after grafting and was 'wasting' at the time of
bleeding. Eight other mice grafted with fresh or deoxyguano-
sine treated (129? x Mov 9S)F1 thymus, and 11 mice grafted
with (C57BL/6Y x Mov 3,)F1 thymus gave consistently
negative tests for reverse transcriptase in serial tail bleedings
taken at intervals up to one year after grafting. Thus,
bearing in mind our observation that very low levels of M-
MuLV can be detected by this protocol, we can conclude
that primary transcription of endogeneous M-MuLV does
not take place in the thymus of Mov 3 or Mov 9 mice. It is
of interest to note the results of Feidler et al. (1982) who
transferred foetal liver and bone marrow cells from Mov-1
mice to sub-lethally irradiated recipients. The grafted mice
were shown to become fully reconstituted with cells carrying
a single genomic copy of M-MuLV at the Mov-l locus, but
none of the mice become viremic or leukaemic indicating
that transcription does not occur in haematopoietic cells.
The role of the thymus in the leukaemogenic process is
poorly understood, but it is obviously important since
mice can be protected from virus or radiation induced
leukaemia by thymectomy. While the thymus presumably
provides a site for M-MuLV infection and replication in
Mov 3 and Mov 9 mice, we have shown that neither stromal
or lymphoid elements are involved in primary activation of
the Mov locus. It remains open to further investigation to
determine the somatic site of primary M-MuLV transcription
in these mice.
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